Subacute liver failure secondary to severe drug-related hepatotoxicity: case report

Authors

DOI:

https://doi.org/10.52784/27112330.124

Keywords:

liver failure, drug-induced liver injury, toxicity, hepatitis, liver transplantation, amiodarone.

Abstract

Acute liver failure is a rare disease with high mortality and a multitude of causes, including drug-induced liver injury, with a difficult differential diagnosis, particularly in the presence of polypharmacy. This pathology is associated with multisystemic organic failure which may require liver transplantation if patient stabilization is not achieved. We present the case of a 50-year-old woman with a 6-week history of right upper quadrant pain, nausea and generalized jaundice, who presented subacute liver failure which ultimately required liver transplantation. We describe the diagnostic approach towards the identification of a probable drug-related cause, due to the use of amiodarone, with a positive outcome for the patient after 3 years of post-transplant follow-up.

Downloads

Download data is not yet available.

Author Biographies

Juan Felipe Morantes-Rubiano, Universidad de La Sabana

Estudiante del XIV semestre de Medicina, Universidad de La Sabana. Chía, Colombia.

Juan Camilo Pérez-Cadavid, Hospital Pablo Tobón Uribe

Médico, Especialista en Patología, Hospital Pablo Tobón Uribe. Medellín, Colombia.

Juan Carlos Restrepo-Gutiérrez, Universidad de Antioquia, Hospital Pablo Tobón Uribe

Médico, Especialista en Medicina Interna, Especialista en Hepatología Clínica, MSc, PhD. Profesor Titular, Facultad de Medicina, Universidad de Antioquia. Jefe Sección Gastrohepatología, Coordinador Especialización en Hepatología Clínica, Grupo Gastrohepatología, Universidad de Antioquia. Coordinador Unidad de Hepatología y Programa de Trasplante de Hígado, Hospital Pablo Tobón Uribe, Universidad de Antioquia. Medellín, Colombia.

Octavio Muñoz-Maya, Hospital Pablo Tobón Uribe, Universidad de Antioquia

Médico, Especialista en Medicina Interna, Especialista en Hepatología Clínica y Trasplante Hepático. Unidad de Hepatología y Trasplante Hepático, Hospital Pablo Tobón Uribe. Profesor Sección de Gastrohepatología, Universidad de Antioquia. Medellín, Colombia.

References

Santos-Sánchez OM. Falla hepática aguda. Hepatología 2020;1:12-22.

Bernal W, Auzinger G, Dhawan A, Wendon J. Acute liver failure. Lancet 2010;376:190-201. https://doi.org/10.1016/S0140-6736(10)60274-7.

Bernal W, Wendon J. Acute liver failure. N Engl J Med 2013;369:2525-2534. https://doi.org/10.1056/NEJMra1208937.

O’Grady JG. Acute liver failure. Postgrad Med J 2005;81:148-154. https://doi.org/10.1136/pgmj.2004.026005.

Grek A, Arasi L. Acute liver failure. AACN Adv Crit Care 2016;27:420-429. https://doi.org/10.4037/aacnacc2016324.

Williams R, Schalm SW, O'Grady JG. Acute liver failure: redefining the syndromes. Lancet 1993;342:273-275. https://doi.org/https://doi.org/10.1016/0140-6736(93)91818-7.

Björnsson ES. Epidemiology, predisposing factors, and outcomes of drug-induced liver injury. Clin Liver Dis 2020;24:1-10. https://doi.org/10.1016/j.cld.2019.08.002.

Tajiri K, Shimizu Y. Practical guidelines for diagnosis and early management of drug-induced liver injury. World J Gastroenterol 2008;14:6774-6785. https://doi.org/10.3748/wjg.14.6774.

Bénichou C. Criteria of drug-induced liver disorders. Report of an international consensus meeting. J Hepatol 1990;11:272-276. https://doi.org/10.1016/0168-8278(90)90124-a.

Caines A, Moonka D. Drug hepatotoxicity: Causality assessment. Clin Liver Dis 2020;24:25-35. https://doi.org/10.1016/j.cld.2019.09.001.

Andrade RJ, Lucena MI, Kaplowitz N, García-Muņoz B, Borraz Y, Pachkoria K, et al. Outcome of acute idiosyncratic drug-induced liver injury: Long-term follow-up in a hepatotoxicity registry. Hepatology 2006;44:1581-1588. https://doi.org/10.1002/hep.21424.

García-Cortés M, Stephens C, Lucena MI, Fernández-Castañer A, Andrade RJ. Causality assessment methods in drug induced liver injury: strengths and weaknesses. J Hepatol 2011;55:683-691. https://doi.org/10.1016/j.jhep.2011.02.007.

Danan G, Benichou C. Causality assessment of adverse reactions to drugs. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol 1993;46:1323-1330. https://doi.org/10.1016/0895-4356(93)90101-6.

Gasmi B, Kleiner DE. Liver histology: Diagnostic and prognostic features. Clin Liver Dis 2020;24:61-74. https://doi.org/10.1016/j.cld.2019.09.004.

Chayanupatkul M, Schiano TD. Acute liver failure secondary to drug-induced liver injury. Clin Liver Dis 2020;24:75-87. https://doi.org/10.1016/j.cld.2019.09.005.

Zhang J, Venkat D. Frequent offenders and patterns of injury. Clin Liver Dis 2020;24:37-48. https://doi.org/10.1016/j.cld.2019.09.002.

Nanau RM, Neuman MG. Adverse drug reactions induced by valproic acid. Clin Biochem 2013;46:1323-1338. https://doi.org/10.1016/j.clinbiochem.2013.06.012.

Gayam V, Mandal AK, Khalid M, Shrestha B, Garlapati P, Khalid M. Valproic acid induced acute liver injury resulting in hepatic encephalopathy: a case report and literature review. J Community Hosp Intern Med Perspect 2018;8:311-314. https://doi.org/10.1080/20009666.2018.1514933.

Stine JG, Chalasani N. Chronic liver injury induced by drugs: a systematic review. Liver Int 2015;35:2343-2353. https://doi.org/10.1111/liv.12958.

National Institute of Diabetes and Digestive and Kidney Diseases. Amiodarone. Livertox: Clinical and research information on drug-induced liver injury. Bethesta, MD: NIDDK; 2016. Acceso 15 de abril de 2020. Disponible en https://www.ncbi.nlm.nih.gov/books/NBK548109/.

Tsuda T, Tada H, Tanaka Y, Nishida N, Yoshida T, Sawada T, et al. Amiodarone-induced reversible and irreversible hepatotoxicity: two case reports. J Med Case Rep 2018;12:95. https://doi.org/10.1186/s13256-018-1629-8.

Jaiswal P, Attar BM, Yap JE, Devani K, Jaiswal R, Wang Y, et al. Acute liver failure with amiodarone infusion: A case report and systematic review. J Clin Pharm Ther 2018;43:129-133. https://doi.org/10.1111/jcpt.12594.

Lewis JH, Ranard RC, Caruso A, Jackson LK, Mullick F, Ishak KG, et al. Amiodarone hepatotoxicity: prevalence and clinicopathologic correlations among 104 patients. Hepatology 1989;9:679-685. https://doi.org/10.1002/hep.1840090504.

Nasser M, Larsen TR, Waanbah B, Sidiqi I, McCullough PA. Hyperacute drug-induced hepatitis with intravenous amiodarone: case report and review of the literature. Drug Healthc Patient Saf 2013;5:191-198. https://doi.org/10.2147/DHPS.S48640.

Li JG, Yang TC, Yu DM, Ren TH. Fatal acute liver failure after intravenous amiodarone administration. J Formos Med Assoc 2015;114:294-296. https://doi.org/10.1016/j.jfma.2013.07.011.

Gluck N, Fried M, Porat R. Acute amiodarone liver toxicity likely due to ischemic hepatitis. Isr Med Assoc J 2011;13:748-752.

Richer M, Robert S. Fatal hepatotoxicity following oral administration of amiodarone. Ann Pharmacother 1995;29:582-586. https://doi.org/10.1177/106002809502900605.

Published

2020-07-19

How to Cite

Morantes-Rubiano, J. F., Pérez-Cadavid, J. C., Restrepo-Gutiérrez, J. C., & Muñoz-Maya, O. (2020). Subacute liver failure secondary to severe drug-related hepatotoxicity: case report. Hepatología, 1(2), 165–175. https://doi.org/10.52784/27112330.124

Issue

Section

Case reports
QR Code
Crossref Cited-by logo